IGCClosing triangle and gap indicator. Possibly another drop to .40s or maybe even .30s This has been a hopeful bottom for many markets.
Next report date
Report period
Q4 2023
EPS estimate
−0.04EUR
Revenue estimate
178.87 KEUR
−0.224EUR
−10.62 MEUR
840.55 KEUR
59.49 M
About IGC Pharma, Inc.
Sector
Industry
CEO
Ram Mukunda
Website
Headquarters
Potomac
Employees (FY)
61
Founded
2005
FIGI
BBG000WHFQF6
IGC Pharma, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications, such as Alzheimer's disease, Parkinson's disease, and pain. The firm is involved in researching the application of cannabinoids, such as Tetrahydrocannabinol and Cannabidiol in combination with other compounds to address various ailments, including Alzheimer's disease. It operates through the Infrastructure Business and Life Sciences segments. The Infrastructure Business segment is involved in the rental of heavy construction equipment, execution of construction contracts, and purchase and resale of physical commodities used in infrastructure. The Life Sciences segment includes a biotech component, and a vertically integrated hemp-cannabinoid based healthcare and wellness business, which involves the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
IgcI'm really for new adventure with this pump and dumb stock.
Buying zone 0.45 - 0.75
Never invest money that you can't afford to lose
Good luck
IGC India Globalization Capital bullish newsAfter the last pump and dump of IGC caused by Cohort 2 of IGC`s Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
now India Globalization Capital comes with another bullish news on the subject: the cannabis-based investigational drug IGC-AD1 was safe and well-tolerated by the Alzheimer’s tr
IGC updateCongratz if you followed my last prediction:
I updated the chart, see above.
I am still confident will we step even higher, but first we have to accept the next pullback.
IGC PullbackIGC started yesterday pretty good, I expect a pullback followed by an bullrun until earnings.
Risk/Reward looks good - Stop Loss at 1.44$.
Lotto Ticket Play, Highly ManipulatedJust something I remembered from a few years back. Love that tradingview play button, so figured I'd post the look just to see what will happen. Noticed it was moving.
Back in 2018, for awhile it was the darling of speculatives in the weed stock sector, rising from sub $1.00 to $15.00. That was
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange IGC PHARMA INC. DL -,01 stocks are traded under the ticker IGS1.
IGC PHARMA INC. DL -,01 is going to release the next earnings report on Jun 20, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track IGC PHARMA INC. DL -,01 financials in yearly and quarterly reports right on TradingView.
IGS1 net income for the last quarter is −5.06 M EUR, while the quarter before that showed −2.32 M EUR of net income which accounts for −118.39% change. Track more IGC PHARMA INC. DL -,01 financial stats to get the full picture.
No, IGS1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IGS1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IGC PHARMA INC. DL -,01 stock right from TradingView charts — choose your broker and connect to your account.
IGS1 reached its all-time high on Oct 2, 2018 with the price of 12.450 EUR, and its all-time low was 0.094 EUR and was reached on Jan 2, 2019. View more price dynamics on IGS1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has 61.00 employees. See our rating of the largest employees — is IGC PHARMA INC. DL -,01 on this list?
We've gathered analysts' opinions on IGC PHARMA INC. DL -,01 future price: according to them, IGS1 price has a max estimate of 3.01 EUR and a min estimate of 3.01 EUR. Watch IGS1 chart and read a more detailed IGC PHARMA INC. DL -,01 stock forecast: see what analysts think of IGC PHARMA INC. DL -,01 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IGC PHARMA INC. DL -,01 EBITDA is −10.00 M EUR, and current EBITDA margin is −1.20 K%. See more stats in IGC PHARMA INC. DL -,01 financial statements.